Your browser doesn't support javascript.
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.
Katsuki, Masahito; Yamagishi, Chinami; Matsumori, Yasuhiko; Koh, Akihito; Kawamura, Shin; Kashiwagi, Kenta; Kito, Tomohiro; Entani, Akio; Yamamoto, Toshiko; Ikeda, Takashi; Yamagishi, Fuminori.
  • Katsuki M; Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan. ktk1122nigt@gmail.com.
  • Yamagishi C; Department of Health Promotion, Itoigawa City, Itoigawa, Niigata, 941-8501, Japan.
  • Matsumori Y; Sendai Headache and Neurology Clinic, Sendai, Miyagi, 982-0014, Japan.
  • Koh A; Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
  • Kawamura S; Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
  • Kashiwagi K; Department of Neurology, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
  • Kito T; Department of Neurosurgery, Nou National Health Insurance Clinic, Itoigawa, Niigata, 949-1331, Japan.
  • Entani A; Department of Internal Medicine, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
  • Yamamoto T; Department of Nursing, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
  • Ikeda T; Department of Health Promotion, Itoigawa City, Itoigawa, Niigata, 941-8501, Japan.
  • Yamagishi F; Department of Surgery, Itoigawa General Hospital, Itoigawa, Niigata, 941-0006, Japan.
Neurol Sci ; 43(6): 3811-3822, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1633886
ABSTRACT

OBJECTIVE:

The medication-overuse headache (MOH) prevalence has not been investigated in a general Japanese population. We performed questionnaire-based survey and revealed MOH prevalence and its characteristics. We also performed clustering to obtain insight for MOH subgrouping.

METHODS:

In this cross-sectional study, the 15-64-year-old population was investigated in Itoigawa during their COVID-19 vaccination under the national policy. MOH was defined as ≥ 15 days/month plus self-report of use of pain medications ≥ 10 or 15 days/month in the last 3 months. Ward method and k-means + + were used to perform clustering MOH patients.

RESULTS:

Among 5865 valid responses, MOH prevalence was 2.32%. MOH was common among females and the middle-aged. Combination-analgesic is the most overused as 50%. MOH had aggravation by routine physical activity, moderate or severe pain, and migraine-like, compared to non-MOH. The 136 MOH patients could be grouped into 3 clusters. Age and frequency of acute medication use were essential factors for clustering.

CONCLUSIONS:

This is the first study of MOH prevalence in Japan. Most MOH characteristics were similar to previous reports worldwide. Public awareness of proper headache treatment knowledge is still needed. Clustering results may be important for subtype grouping from a social perspective apart from existing clinical subtypes.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Headache Disorders, Secondary / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Neurol Sci Journal subject: Neurology Year: 2022 Document Type: Article Affiliation country: S10072-021-05831-w

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Headache Disorders, Secondary / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Neurol Sci Journal subject: Neurology Year: 2022 Document Type: Article Affiliation country: S10072-021-05831-w